Skip to main content
. 2018 Apr 27;26(7):1771–1782. doi: 10.1016/j.ymthe.2018.04.023

Figure 5.

Figure 5

GYS2-1 Treatment Prevents Nodule Development in the Agl−/− GSD III Mouse Model

Agl−/− mice were treated with PBS or GYS2-1 monthly for 12 doses starting at one month of age. Liver samples were collected 72 hr following the final dose. (A) Histological analysis was performed in prepared liver samples. The scale bar represents 100 μm. Each liver image shows a representative section from an individual animal. (B) Higher magnification images of sections of the nodules are shown. The scale bars represent 500 or 100 mm in the upper or lower panel, respectively.